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The balance between excitatory and inhibitory synaptic inputs,
which is governed by multiple synapse organizers, controls neural
circuit functions andbehaviors. Slit- andTrk-like proteins (Slitrks) are
a family of synapse organizers, whose emerging synaptic roles are
incompletely understood. Here, we report that Slitrks are enriched
in postsynaptic densities in rat brains. Overexpression of Slitrks
promoted synapse formation, whereas RNAi-mediated knock-
down of Slitrks decreased synapse density. Intriguingly, Slitrks
were required for both excitatory and inhibitory synapse formation
in an isoform-dependent manner. Moreover, Slitrks required dis-
tinct members of the leukocyte antigen-related receptor protein
tyrosine phosphatase (LAR-RPTP) family to trigger synapse forma-
tion. Protein tyrosine phosphatase σ (PTPσ), in particular, was spe-
ciﬁcally required for excitatory synaptic differentiation by Slitrks,
whereas PTPδwas necessary for inhibitory synapse differentiation.
Taken together, these data suggest that combinatorial interactions
of Slitrks with LAR-RPTP family members maintain synapse forma-
tion to coordinate excitatory–inhibitory balance.
leucine-rich repeat | neuropsychiatic disorder | synaptic cell-adhesion
Synaptic cell-adhesion molecules (CAMs) direct various stagesof synaptogenesis, the process of synapse creation involving the
assembly, maturation, validation, and speciﬁcation of specialized
sites of asymmetrical junctions between neurons (1). The list of
known synaptic CAMs has expanded rapidly, although the precise
synaptic functions of most CAMs remain incompletely understood.
Among the various CAMs, neuronal transmembrane proteins con-
taining extracellular leucine-rich repeat (LRR) domains, in particu-
lar, have received considerable research attention (2–4).
The Slit- and Trk-like (Slitrk) proteins constitute one such
LRR domain-containing family. Originally identiﬁed in a screen
for genes that were differentially expressed in mice with neural
tube defects (5), Slitrks are type I transmembrane proteins with
extracellular domains containing two clusters of LRRs. Mem-
bers of the Slitrk family, which consists of six proteins (Slitrk1–6)
(5), are highly and widely expressed in the CNS (6). Intriguingly,
Slitrk isoforms have been associatedwithmultiple neuropsychiatric
disorders. For example, Slitrk1 variants are linked to the spectrum
of obsessive-compulsive disorders (OCDs), Tourette syndrome,
and trichotillomania (7, 8), and Slitrk2 is associated with schizo-
phrenia and bipolar disorder (9, 10). Moreover, Slitrk1 mutant
mice show anxiety-like behaviors and Slitrk5-deﬁcient mice display
OCD-like behaviors (11, 12). Recently, Slitrk3 was shown to con-
trol inhibitory synapse development selectively (13). Despite this
progress, little about the synaptic functions of other Slitrk isoforms,
apart from their ability to regulate neurite outgrowth (14), has been
studied in detail.
The leukocyte antigen-related receptor protein tyrosine phos-
phatase (LAR-RPTP) family is composed of threemembers: LAR,
protein tyrosine phosphatase δ (PTPδ), and PTPσ, all of which
share a similar domain organization comprising three Ig domains
and four to eight ﬁbronectin type III repeats. LAR-RPTP family
members are evolutionarily conserved and are functionally required
for axon guidance and synapse formation (15). Recent studies have
shown that netrin-G ligand-3 (NGL-3), neurotrophin receptor ty-
rosine kinase C (TrkC), and IL-1 receptor accessory protein-like 1
(IL1RAPL1) bind to all three LAR-RPTP family members or dis-
tinct members of the family; however, the functional signiﬁcance of
these multifaceted interactions remains elusive (16–18).
Here, we systematically investigated the effects of hippo-
campal Slitrk isoforms on synapse structure and function in
cultured hippocampal neurons using both gain-of-function and
loss-of-function strategies. Slitrk expression was detected in the
postsynaptic density in brains. Strikingly, we found that a subset
of Slitrk isoforms (Slitrk1, Slitrk2, Slitrk4, and Slitrk5) speciﬁ-
cally acted at excitatory synapses in various functional assays. In
contrast, Slitrk3 acted exclusively at inhibitory synapses. Impor-
tantly, we found that distinct members of the LAR-RPTP family
mediated different outcomes: PTPσ was required for triggering
excitatory presynaptic differentiation, whereas PTPδwas necessary
for inhibitory presynaptic differentiation. Taken together, our data
suggest that Slitrk isoforms collaborate with distinct members of
the LAR-RPTP family to specify the development of speciﬁc
synapse types in cultured hippocampal neurons.
Results
Slitrks Are Expressed in Postsynaptic Density Fractions in Rat Brains.
To examine Slitrk protein expression in brains, we ﬁrst generated
a Slitrk1-speciﬁc antibody that does not cross-react with other
Slitrks (Fig. S1 A and B). Using this antibody as well as commer-
cially available Slitrk antibodies (for Slitrk2, Slitrk3, and Slitrk4),
we examined the expression patterns of Slitrk proteins in rat tis-
sues. Slitrk protein expressionwasmainly detected in the brain and
not in other tissues (Fig. 1A). The expression of Slitrks steadily
increased during embryonic and postnatal brain development (Fig.
1B), a pattern similar to that of postsynaptic density protein 95 kDa
(PSD-95). Slitrk proteins were widely distributed in rat brains (Fig.
1C) and were detected in various subcellular fractions, including
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synaptosomes and synaptic membrane fractions (Fig. 1D and
Fig. S1C). Notably, Slitrk2 exhibited unique subcellular local-
izations, with its immature form mainly distributed to the cyto-
solic fractions. Slitrk1 was enriched in PSD fractions up to
PSDIII, which is highly detergent-resistant (Fig. 1E). Other Slitrks
showed a similar enrichment in PSD fractions, albeit to a lesser
extent; however, Slitrk2 was not enriched in PSD fractions. The
used antibodies detected mature (i.e., N-glycosylated) Slitrks in
both rat brains and cultured neurons, with the exception of anti-
Slitrk4 (19) (Fig. 1F and Fig. S1 D and E).
Overexpression of Slitrks Increases Synapse Density. Because Slitrks
are biochemically detected in synaptic fractions, we next asked
whether Slitrks regulate synapse formation and/or maturation. As
a gain-of-function approach, we cotransfected neurons at 10 d in
vitro (DIV10) with expression vectors encoding full-length Slitrks
[Slitrk1–5 excluding Slitrk6; an explanation is provided by Beau-
bien and Cloutier (6), as well as below] and EGFP to visualize the
cellular morphology of transfected neurons, and we immuno-
stained the transfected neurons for the synapticmarkers Synapsin I,
vesicular glutamate transporter 1 (VGLUT1; an excitatory pre-
synaptic marker), glutamic acid decarboxylase 67 kDa (GAD-67;
an inhibitory presynaptic marker), PSD-95 (an excitatory post-
synaptic marker), and/or gephyrin (an inhibitory postsynaptic
marker) at DIV14 (Fig. 2 and Fig. S2). For each of the ﬁve Slitrks,
overexpression in cultured hippocampal neurons drastically in-
creased synapse density, monitored as the number of Synapsin I
puncta, producing effects similar to those of previously discovered
synaptic adhesion molecules, such as neuroligins (NLs), leucine-
rich repeat transmembrane neuronal proteins (LRRTMs), and
NGLs (20–22) (Fig. 2 A and D). Whether the increases in synapse
density were general or speciﬁc to a particular synapse type was
determined by evaluating the number of presynaptic (VGLUT1
and GAD-67) or postsynaptic (PSD-95 and gephyrin) puncta (Fig.
2 B–D and Fig. S2 A–C). Interestingly, overexpression of Slitrk1,
Slitrk2, Slitrk4, or Slitrk5 speciﬁcally promoted excitatory synapse
formation, whereas overexpression of Slitrk3 did not (Fig. 2 B and
Fig. 1. Expression patterns of Slitrk proteins in rat brains. (A) Tissue ex-
pression of Slitrk proteins, revealed by immunoblot analysis with anti-Slitrk
antibodies. mus., muscle; Sk., skeletal. (B) Expression levels of Slitrk proteins
during development. E, embryonic day; P, postnatal day. α-tubulin was used
for normalization. (C) Regional distribution of Slitrk proteins in various rat
brain areas, revealed by immunoblotting of brain homogenates. Bs, brain-
stem; Cbl, cerebellum; Ctx, cerebral cortex; Hpc, hippocampus; Sc, spinal
cord. α-Tubulin was used for normalization. (D) Distribution of Slitrk proteins
in subcellular fractions of rat brains. H, homogenates; LP1, synaptosomal
membrane fraction; LP2, synaptic vesicle-enriched fraction; P1, nuclear pel-
let; P2, crude synaptosomes; P3, light membrane fraction; S2, supernatant
after P2 precipitation; S3, cytosol. A total of 15 μg of each fraction was
loaded in immunoblot experiments. PSD-95 and synaptophysin (SynPhys)
were used as positive controls. (E ) Enrichment of Slitrk proteins in PSD
fractions, extracted with Triton X-100 once (PSDI) or twice (PSDII), or with
Triton X-100 plus sarkosyl (PSDIII). A total of 5 μg of crude synaptosomes (P2)
and PSD fraction samples was loaded in immunoblot experiments. Note that
Slitrk2 was not enriched in PSD fraction samples. PSD-95 and SynPhys were
used as positive controls. (F) N-glycosylation of Slitrk proteins in rat brains.
The crude synaptosome (P2) fraction of adult rat brain was subjected to
PNGase F digestion, followed by immunoblot analyses with the indicated
antibodies. SynPhys was used as a positive control. Temp, temperature (°C).
Note that the anti-Slitrk4 antibody detected only immature species of
Slitrk4 proteins, because PNGase F digestion did not shift the band position.
Molecular mass markers are labeled in kilodaltons in A–F.
Fig. 2. Overexpression of Slitrks increases synapse density in cultured hip-
pocampal neurons. Representative images of hippocampal neurons trans-
fected with the indicated expression vectors at DIV10 and analyzed by double
immunoﬂuorescence with antibodies to GFP and Synapsin I (A), VGLUT1 (B),
or GAD-67 (C) at DIV14. (Scale bar: A–C, 5 μm.) (D) Quantitative bar graphs of
synapse density in images in A–C. Data shown are means ± SEMs (two to
three dendrites per transfected neuron were analyzed and group-averaged).
Statistical signiﬁcance was assessed by comparing the various conditions with
controls using the Student t test (2*P < 0.01; 3*P < 0.001).
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D and Fig. S2 A–C). Instead, overexpression of Slitrk3 led to
a modest increase in inhibitory synapse density (Fig. 2 C and D),
indicating that gain-of-function manipulations of Slitrk isoforms
exert differential effects on synapse numbers in cultured hippo-
campal neurons. Consistent with this observation, investigation of
subcellular localization of recombinant Slitrk1 and Slitrk2 in cul-
tured hippocampal neurons, visualized by monitoring expression
of Slitrk1 monomeric Venus (mVenus) ﬂuorescent protein-fused
Slitrk1 (Slitrk1-mVenus) and Slitrk2 (Slitrk2-mVenus) showed
that Slitrk1-mVenus and Slitrk2-mVenus puncta were present in
excitatory, but not inhibitory, synapses of transfected neuronal
dendrites (Fig. S3 A–C). Recombinant Slitrk3 was shown to lo-
calize exclusively to inhibitory synapses (13). Slitrk overexpression
did not change other morphological parameters, such as synapse
size or synapse strength, assessed by measuring puncta size and
intensity, respectively (Fig. S3D). Taken together, these results
suggest that Slitrks are differentially localized to distinct synapse
types and regulate the formation of the respective synapses in an
isoform-dependent manner.
Knockdown of Slitrks Decreases Synapse Density.To address whether
Slitrks are required for the formation of synapse structure, we
ﬁrst generated a series of lentiviral vectors expressing shRNA
targeting individual Slitrks (Table S1). We then infected cul-
tured rat cortical neurons with each of these knockdown (KD)
lentiviruses and assessed endogenous target mRNA and pro-
tein levels by quantitative real-time RT-PCR and quantitative
immunoblotting, respectively (Fig. 3 A–C and Fig. S4 A and B).
We excluded Slitrk6 because it exhibits little or no expression in
the hippocampus (6). The shRNA sequences used suppressed en-
dogenous mRNA by ∼80% for Slitrk1, ∼75% for Slitrk2, ∼75%
for Slitrk3, ∼70% for Slitrk4, and ∼75% for Slitrk5 (Fig. S4A), and
they reduced the levels of endogenous proteins by ∼75% for
Slitrk1, ∼70% for Slitrk2, ∼70% for Slitrk3, and ∼65% for Slitrk4
(Fig. 3 B and C and Fig. S4B). We also found that each Slitrk
shRNA sequence speciﬁcally affected the level of only the
targeted isoform and not off-target isoforms (Fig. S5). We next
investigated whether single KD of Slitrk1, Slitrk2, Slitrk3, Slitrk4,
or Slitrk5 altered synapse number and/or size in cultured hippo-
campal neurons. To accomplish this, we transfected cultured
neurons at DIV8 with lentiviral expression vectors that expressed
only EGFP (control) or coexpressed EGFP with shRNAs against
Slitrk1 (K4), Slitrk2 (K11), Slitrk3 (K15), Slitrk4 (K17), or Slitrk5
(K21), and we immunostained neurons at DIV14 for Synapsin I,
VGLUT1, and GAD-67 (Fig. 3 D–I). We found that single KD of
each Slitrk signiﬁcantly reduced synapse numbers (Fig. 3 D–E),
indicating that all ﬁve Slitrks contribute to the formation of synapse
structure.Moreover, singleKDof Slitrk1, Slitrk2, Slitrk4, or Slitrk5
caused a modest but signiﬁcant decrease in excitatory synapse
density but not inhibitory synapse density (Fig. 3 F and G). In
contrast, single KD of Slitrk3 led to a speciﬁc reduction in in-
hibitory synapse density (13) (Fig. 3 H and I). Slitrk KD did not
affect synapse size under any experimental conditions (Fig. S4C).
More importantly, coexpression of a shRNA-resistant form of
Slitrk1, Slitrk2, Slitrk3, Slitrk4, or Slitrk5 (i.e., rescue vectors)
completely eliminated the deﬁcits in synapse density observed
with the corresponding Slitrk KDs (Fig. 3 D and E, Fig. S6A, and
Table S2). Expression of a scrambled shRNA (sc-shRNA) vector
against each of the Slitrk isoforms tested (Slitrk1–5) had absolutely
no effect on synapse density, conﬁrming that the observed pheno-
types are due to speciﬁc isoform KD and not off-target effects (23)
(Figs. S5 and S6 B and C and Table S3). Collectively, these results
corroborate the notion that individual Slitrks play critical roles in
maintaining synapse structure at distinct synapse types.
Slitrks Interact with PTPδ or PTPσ but Not with LAR. To identify
presynaptic ligands of postsynaptic Slitrks, we performed afﬁnity
chromatography of solubilized rat brains using recombinant Slitrk1
Fig. 3. KD of Slitrks reduces synapse numbers in cultured hippocampal
neurons. (A) Design of lentiviral shRNA vectors for KD of Slitrk1, Slitrk2,
Slitrk3, Slitrk4, or Slitrk5. H1, human H1 promoter; IRES, internal ribosome
entry sequence; Ub, ubiquitin promoter. Slitrk rescue vectors were constructed
by inserting shRNA-resistant, full-length Slitrk1 or Slitrk2 in-frame into the
corresponding Slitrk KD vector. (B) Representative immunoblots of lysates of
cortical neurons infected with potent lentiviral shRNAs (K4, Slitrk1; K11,
Slitrk2; K15, Slitrk3; K17, Slitrk4) at DIV2, harvested at DIV12, and probed
using anti-Slitrk antibodies (Fig. S5B). Slitrk5 was not investigated due to the
lack of suitable antibodies. α-tubulin was used for normalization. (C) Levels of
the target proteins, Slitrk1 (K4), Slitrk2 (K11), Slitrk3 (K15), and Slitrk4 (K17)
in B measured by semiquantitative immunoblotting. The dotted line indicates
the 65% KD cutoff level for tests of biological effects. (D) Representative
images of cultured hippocampal neurons infected at DIV8 with a lentiviral
vector expressing EGFP only (Control) or coexpressing EGFP and Slitrk1-KD
(with/without Slitrk1/2 rescue vectors), Slitrk2-KD (with/without Slitrk2 rescue
vector), Slitrk3-KD, Slitrk4-KD, or Slitrk5-KD, and analyzed by double immu-
noﬂuorescence with antibodies to GFP and Synapsin I at DIV14. (Scale bar:
5 μm.) (E) Summary graphs of the effects of single KD of Slitrk1, Slitrk2, Slitrk3,
Slitrk4, or Slitrk5 on synapse density (quantiﬁed using Synapsin I immunore-
activity) and phenotypic restoration by Slitrk1 (+Slitrk1), Slitrk2 (+Slitrk2),
Slitrk3 (+Slitrk3), Slitrk4 (+Slitrk4), or Slitrk5 (+Slitrk5) rescue vectors. S1, S2, S3,
S4, and S5 denote the Slitrk1, Slitrk2, Slitrk3, Slitrk4, and Slitrk5 single-
isoform KD condition. The rest of rescue images is presented in Fig. S6A. (F)
Same as in D, except that anti-VGLUT1 antibodies were used for immuno-
cytochemistry analyses. (Scale bar: 5 μm.) (G) Summary graphs of the effects
of single KD of Slitrk1, Slitrk2, Slitrk3, Slitrk4, or Slitrk5 on excitatory synapse
density, quantiﬁed using VGLUT1 immunoreactivity. (H) Same as D, except
anti–GAD-67 antibodies were used for immunocytochemical analyses. (Scale
bar: 5 μm.) (I) Summary graphs of the effects of single KD of Slitrk1, Slitrk2,
Slitrk3, Slitrk4, or Slitrk5 on inhibitory synapse density, quantiﬁed using
GAD-67 immunoreactivity. Data shown in E, G, and I are means ± SEMs.
Statistical signiﬁcance was assessed by comparing the various conditions
with controls using the Student t test (*P < 0.05; 2*P < 0.01; 3*P < 0.001).
















fusion proteins immobilized on protein A-Sepharose (Ig-Slitrk1).
Mass spectroscopy analyses revealed seven peptides encoding the
type II receptor PTPδ (details are provided in Table S4). Recently,
Takahashi et al. (13) also reported that PTPδ binds to Slitrks in
vitro, consistent with this observation. However, whether other
members of the type IIb RPTP family (i.e., LAR and PTPσ; col-
lectively termed LAR-RPTPs hereafter) can also bind Slitrks has
not been tested.
Using cell-adhesion assays to address this possibility, we found that
Slitrk1-, Slitrk2-, or Slitrk3-expressing L cells speciﬁcally aggregated
with PTPδ-expressing L cells (Fig. 4 A and B), consistent with data
obtained in cell surface labeling assays using IgC-PTPδ recombinant
proteins (13). Similarly, Slitrk1-, Slitrk2-, or Slitrk3-expressing cells
aggregated with PTPσ-expressing cells (Fig. 4 A and B). Strikingly,
Slitrk-expressing cells did not aggregate with LAR-expressing cells;
in contrast,NGL-3–expressing cells showed strong adhesive activities
Fig. 4. Interaction of Slitrks with LAR-RPTPs and effects of individual LAR-RPTP KD on Slitrk activities in artiﬁcial synapse-formation assays. (A) Representative
images of cell-adhesion assays using L cells doubly transfected with expression constructs for EGFP and Slitrk isoforms (Slitrk1, Slitrk2, or Slitrk3) or CD8
(negative control), mixed with a separate group of L cells doubly transfected with DsRed and LAR-RPTP isoforms (PTPδ, PTPσ, or LAR). (Scale bar: 100 μm.) (B)
Quantiﬁcation (average number of clusters per frame) of results shown in A. Data shown are means ± SEMs. Statistical signiﬁcance was assessed by comparing
the various conditions with controls using the Student t test (3*P < 0.001). (C) Hippocampal neurons infected at DIV1–3 with control lentiviruses (Control
shRNA) or shRNA-expressing PTPδ-KD (PTPδ shRNA), PTPσ-KD (PTPσ shRNA), or LAR-KD (LAR shRNA) were cocultured for 3 d (DIV10–13) with HEK293T cells
expressing EGFP alone (Control) or coexpressing EGFP and Slitrk1 (Slitrk1 + EGFP), Slitrk2 (Slitrk2 + EGFP), or Slitrk3 (Slitrk3 + EGFP). Panels show repre-
sentative images of cocultures stained with antibodies to EGFP (green) and excitatory (VGLUT1) or inhibitory (GAD-67) synaptic markers (red). Coincident
green and red signals are shown in yellow. (Scale bar: 25 μm.) (D) Quantiﬁcation of the artiﬁcial synapse-formation activity of Slitrks shown in C. Activity was
quantiﬁed by measuring the ratio of synaptic marker staining to EGFP ﬂuorescence (for absolute red and green ﬂuorescence values). Statistical signiﬁcance
was assessed by comparing the various conditions with controls using the Student t test (*P < 0.05; 2*P < 0.01; 3*P < 0.001). (E) Levels of target mRNAs (PTPδ,
PTPσ, and LAR) measured by quantitative RT-PCR in cultured cortical neurons infected at DIV1–3 with lentiviruses expressing the indicated shRNAs (J51, PTPδ;
J56, PTPσ; J60, LAR). mRNA levels were determined at DIV12 (dotted line: 70% KD cutoff level). Note that each shRNA vector speciﬁcally suppressed the mRNA
levels of its target isoform but not those of off-target isoforms.
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toward LAR-expressing cells [consistent with the ﬁndings of Woo
et al. (6)] (Fig. S7 A and B). To conﬁrm that Slitrks do not interact
with LAR, we incubated HEK293T cells coexpressing EGFP and
Slitrk isoforms (Slitrk1, Slitrk2, and Slitrk3) or NGL-3 (positive
control) with LAR-Ig fusion or IgC (negative control) and found that
LAR did not bind to any Slitrks examined but did bind to NGL-3
(Fig. S7C). We could not perform similar analyses with PTPδ or
PTPσ because the yield of recombinant PTPδ and PTPσ proteins
was insufﬁcient. These results are puzzling when viewed in light
of the structural similarities among LAR-RPTP family members.
However, it is not unreasonable to suppose that only PTPδ and
PTPσ bind to Slitrks, considering the existence of multiple post-
synaptic ligands that bind only to distinct LAR-RPTPs (21, 22).
Differential Requirement of LAR-RPTPs in Promoting Excitatory vs.
Inhibitory Synapse Development. We then addressed whether
LAR-RPTP family members are important for the synapto-
genic activities of Slitrks in artiﬁcial synapse-formation assays
(24). First, we transfected HEK293T cells with pDisplay-Slitrk
containing only extracellular regions of Slitrks or untagged
Slitrk expression constructs, and we cocultured these cells with
hippocampal neurons (Fig. 4 C and D and Fig. S8). We conﬁrmed
that all Slitrks strongly recruited the presynaptic markers Synapsin
I, VGLUT1, and/or GAD-67, but not the postsynaptic marker
PSD-95, to HEK293T cells (Fig. 4 C and D and Fig. S8).
To examine whether LAR-RPTPs are required for the synapto-
genic activities conferred by Slitrks, we developed shRNA lentivi-
ruses that speciﬁcally knocked down individual LAR-RPTP family
members (Fig. 4E). We then infected cultured neurons with lenti-
viruses expressing either an empty shRNA vector (control shRNA)
or an shRNA KD construct targeting LAR (LAR shRNA), PTPδ
(PTPδ shRNA), or PTPσ (PTPσ shRNA), and we undertook an
extensive series of artiﬁcial synapse-formation assays using in-
fected neurons andHEK293T cells expressing Slitrk1, Slitrk2, or
Slitrk3 vectors (Fig. 4 C and D). Intriguingly, PTPδ KD resulted
in failure of a variety of Slitrks to induce GAD-67 recruitment
but did not affect VGLUT1 clustering (Fig. 4 C and D). In con-
trast, PTPσKD resulted in a failure of Slitrk1 and Slitrk2 to induce
VGLUT1 clustering on contacting axons of cocultured hippo-
campal neurons but did not affect GAD-67 recruitment (Fig. 4 C
and D). Moreover, infection of cultured neurons with lentiviruses
expressing the scrambled version of either PTPδ KD (PTPδ sc-
shRNA) or PTPσKD (PTPσ sc-shRNA) had no noticeable effects
on the synaptogenic activities of Slitrks, indicating no off-target
biological actions of the shRNA vectors used in this study (Fig. 4E
and Fig. S9). In parallel experiments, LAR KD did not alter the
synaptogenic activities of Slitrks, suggesting that LAR is not a
major presynaptic receptor for the synaptogenic actions of Slitrks.
These results are consistent with the binding data showing that
LAR does not bind any Slitrks examined (Fig. 4 A and B and Fig.
S7). Taken together, these data indicate that Slitrks physio-
logically use distinct LAR-RPTP isoforms to trigger excitatory
and inhibitory synapse formation selectively.
Discussion
Recent studies have established that a host of neuronal trans-
membrane proteins containing LRR domains play important roles
in synapse development, although the precise functions of these
proteins are only slowly being uncovered (3, 13, 17, 20, 25–27). Six
Slitrk family members (Slitrk1–6) share similar domain organ-
izations and have been shown to regulate neurite outgrowth in
Pheochromocytoma Cell Line 12 (PC12) cells (5, 28). Intriguingly,
various Slitrk-KO mice exhibit a range of neurological behaviors,
implying differential functions of these proteins in the CNS (12,
29, 30). However, potential isoform-speciﬁc synaptic functions of
Slitrk family members have not yet been systematically explored.
In the present study, we utilized a series of functional approaches
to explore the synaptic functions of Slitrk proteins using cultured
hippocampal neurons as a model system. We also performed an
extensive array of artiﬁcial synapse-formation assays in con-
junction with loss-of-function manipulations of the LAR-RPTP
family to probe the mechanisms underlying the synaptogenic ac-
tivities of Slitrks. We made four principal observations. First,
immunoblot analyses revealed that Slitrks are widely expressed in
rat brains. Speciﬁcally, we found that Slitrk1, Slitrk3, and Slitrk4
are enriched in PSD fractions (Fig. 1). However, considering the
inherent limitations of the protocol used to isolate PSD fractions
in this study (31), caution should be applied in interpreting bio-
chemical enrichment of Slitrk isoforms in PSD fractions as de-
ﬁnitive evidence for localization of these isoforms at speciﬁc
synapse types. Indeed, Slitrk3 was shown to be speciﬁcally local-
ized to and to function at inhibitory synapses, but it appeared to be
biochemically enriched in the PSD fractions in this study, as well
as in the study by Takahashi et al. (13). Second, overexpression of
individual Slitrk isoforms markedly increased the density of both
excitatory and inhibitory synapses in cultured hippocampal neu-
rons (Fig. 2). These ﬁndings are reminiscent of observations of
other synaptic proteins, such as NLs, LRRTMs, and NGLs (16, 25,
32). Although LRRTMs and NGLs act speciﬁcally on excitatory
synapses, Slitrks were found to function in both excitatory and in-
hibitory synapses, with Slitrk1, Slitrk2, Slitrk4, and Slitrk5 acting on
excitatory synapses and Slitrk3 acting on inhibitory synapses. These
results provide strong evidence that Slitrks play a central role in
general synapse formation, similar to that of NLs (21) (Fig. 2).
Notably, Slitrk3 functioned like NL2, indicating that a distinct
molecular determinant in Slitrk3 mediates its exclusive targeting to
inhibitory synapses. Third, KD of Slitrks led to impairments in
synapse structure (Fig. 3). Individual KD of Slitrk1, Slitrk2, Slitrk4,
or Slitrk5 decreased the number of excitatory synapses. In contrast,
KD of Slitrk3 speciﬁcally reduced the number of inhibitory syn-
apses (Fig. 3). Systematic analyses of KO mice deﬁcient in the ex-
pression of Slitrk(s) should be performed to validate the RNAi
phenotypes documented in this study. Fourth, Slitrks appeared to
interact with both PTPδ and PTPσ but not with LAR, at least in
vitro (Fig. 4 A and B and Fig. S7). Strikingly, Slitrks required dis-
tinct presynaptic receptors to trigger speciﬁc types of presynapses:
KD of PTPσ speciﬁcally attenuated the synaptogenic activities of
Slitrk1 and Slitrk2 on excitatory synapses, whereas KD of PTPδ
completely abolished the synaptogenic activities of Slitrks on in-
hibitory synapses (13) (Fig. 4 C and D). In contrast to a previous
report that PTPδ is responsible for mediating induction of excit-
atory presynapses by IL1RAPL1 (18), these results suggest that
individual Slitrks functionally use a different set of extracellular
ligands to accelerate presynaptic development. We speculate that
individual members of the LAR-RPTP family link to unique sets of
cytoplasmic proteins that mediate activation of intracellular sig-
naling cascades, leading to formation of either excitatory or in-
hibitory synapses, depending on signals from the postsynaptic side.
In support of speculation, it has been shown that LAR-RPTP
family members are differentially localized to distinct synapse
types (13, 17, 33). PTPδ is exclusively localized to axons of in-
hibitory synapses, whereas PTPσ is exclusively localized to axons of
excitatory synapses in cultured hippocampal neurons (13, 17). The
differential localization of LAR-RPTP members partly explains
why KD of each LAR-RPTP isoform exerts distinct effects in ar-
tiﬁcial synapse-formation assays (Fig. 4 C and D). However, these
results cannot fully account for why overexpression of Slitrk iso-
forms affects distinct synapse types. One possible explanation can
be found in the presynaptic ligand interaction-independent activ-
ities of Slitrk isoforms, which are quite reminiscent of NL1 (22).
Therefore, structural information detailing how Slitrks associate
with LAR-RPTP family members should provide mechanistic in-
sight into why different LAR-RPTPs have unique catalogs of
postsynaptic receptors.
Overall, our results conﬁrm the notion that Slitrks are bona
ﬁde synaptic CAMs. It is likely that Slitrks collaborate with other
















known synaptic CAMs to maintain the structure and function of
synapses, particularly together with other synaptic CAMs that
also interact with LAR-RPTPs in a combinatorial manner (16–
18). In addition, our data establish that different Slitrk isoforms
have differential functions, a ﬁnding reminiscent of the previous
observation that overexpression of each Slitrk isoform differen-
tially affects neurite outgrowth in PC12 cells, whose activities
are conferred by their unique cytoplasmic regions (5). Although
the precise mechanism governing synaptic adhesion between
Slitrks and LAR-RPTPs remains elusive, the fact that Slitrks
and LAR-RPTPs serve double duty as inducers of either excit-
atory or inhibitory synapses places these protein families at center
stage in the control of excitatory–inhibitory balance, which is
critical for neuronal function (34). Indeed, genetic mutations of
a subset of Slitrks have been associated with multiple neuro-
psychiatric diseases (7, 9, 10). In support of this idea, Slitrk1 is
expressed in neural circuits of basal ganglia implicated in Tourette
syndrome (35). Although many neuropsychiatric disorders, par-
ticularly autism spectrum disorders, are thought to occur as a re-
sult of an imbalance between excitatory and inhibitory synapses,
whether the spectrum of OCDs reﬂects a similar excitatory–in-
hibitory imbalance has not yet been established (36). Our work
underscores the notion that Slitrks and their trans-synaptic sig-
naling pathways are linked to pathophysiological mechanisms
underlying related neuropsychiatric diseases.
Our study raises a number of questions that need to be
addressed. Can KO of other Slitrk isoforms recapitulate the
excitatory–inhibitory imbalance observed in Slitrk3-KO mice?
Why do very similar proteins within the same family (i.e., Slitrks,
LAR-RPTPs) activate different functional trans-synaptic path-
ways? Do Slitrks function similarly or differently in other brain
regions that are particularly relevant for the occurrence of the
spectrum of OCDs (i.e., cortex, striatum, thalamus)? The de-
ﬁnitive answers to these questions will shed light on the detailed
molecular mechanisms underlying the function of Slitrks in syn-
apse formation and could unveil the pathophysiological mecha-
nisms by which Slitrk dysfunction contributes to the behavioral
and cognitive deﬁcits in related neuropsychiatric conditions.
Methods
Expression constructs and antibodies used in this study were described in
detail in SI Text. Artiﬁcial synapse-formation assays, cell-adhesion assays, and
cell surface labeling assays were performed with HEK293T cells as previously
described (22, 30). Generation of lentiviral shRNA plasmids and production
and characterization of recombinant lentiviruses were performed as pre-
viously described (37) and are detailed in SI Text.
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